TY - JOUR
T1 - Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group
AU - Silakit, Runglawan
AU - Loilome, Watcharin
AU - Yongvanit, Puangrat
AU - Thongchot, Suyanee
AU - Namwat, Nisana
AU - Sithithaworn, Paiboon
AU - Boonmars, Thidarut
AU - Koonmee, Supinda
AU - Titapun, Attapol
AU - Khuntikeo, Narong
AU - Chamadol, Nittaya
AU - Techasen, Anchalee
N1 - Publisher Copyright:
© 2015 Elsevier Ireland Ltd
PY - 2017/8
Y1 - 2017/8
N2 - Opisthorchis viverrini infection induces chronic inflammation in the bile ducts, leading to periductal fibrosis (PDF), which possibly associates to cholangiocarcinoma (CCA). Patients with CCA have a poor prognosis, which is linked to asymptomatic disease and late diagnosis. Hence, detecting early stage CCA is essential. Secretory miRNAs have been promoted as biomarkers for pathological changes associated with parasitic infections, fibrosis and/or cancer. We aimed to determine levels of miR-192 and miR-21 in the urine of O. viverrini infected, periductal fibrosis (PDF) and CCA groups using qRT-PCR. We found that miR-192 was significantly higher in O. viverrini infected, PDF and also CCA groups (p < 0.05) than in healthy controls. By utilizing the Receiver Operation Characteristics (ROC) analysis, miR-192 differentiated patients with opisthorchiasis (the area under the curve; AUC = 0.766), PDF subjects (AUC = 0.781) and CCA patients (AUC = 0.682) from healthy controls. MiR-21 was significantly higher in PDF and CCA groups (p < 0.05) than in healthy controls. MiR-21 discriminated PDF subjects (AUC = 0.735) and CCA patients (AUC = 0.682) from healthy controls. Combined levels of these two miRNAs revealed an increased AUC of 0.812 for separating opisthorchiasis, AUC of 0.815 in discriminating PDF subjects, and AUC of 0.849 in differentiating CCA from healthy controls. Odds ratios (OR) indicated high levels of miR-192/miR-21 as risk predictors for opisthorchiasis, PDF and CCA. Levels of these miRNAs declined significantly for patients following praziquantel treatment. In conclusion, urinary miR-192/miR-21 have potential as risk indicators for opisthorchiasis and PDF-associated CCA in the endemic region.
AB - Opisthorchis viverrini infection induces chronic inflammation in the bile ducts, leading to periductal fibrosis (PDF), which possibly associates to cholangiocarcinoma (CCA). Patients with CCA have a poor prognosis, which is linked to asymptomatic disease and late diagnosis. Hence, detecting early stage CCA is essential. Secretory miRNAs have been promoted as biomarkers for pathological changes associated with parasitic infections, fibrosis and/or cancer. We aimed to determine levels of miR-192 and miR-21 in the urine of O. viverrini infected, periductal fibrosis (PDF) and CCA groups using qRT-PCR. We found that miR-192 was significantly higher in O. viverrini infected, PDF and also CCA groups (p < 0.05) than in healthy controls. By utilizing the Receiver Operation Characteristics (ROC) analysis, miR-192 differentiated patients with opisthorchiasis (the area under the curve; AUC = 0.766), PDF subjects (AUC = 0.781) and CCA patients (AUC = 0.682) from healthy controls. MiR-21 was significantly higher in PDF and CCA groups (p < 0.05) than in healthy controls. MiR-21 discriminated PDF subjects (AUC = 0.735) and CCA patients (AUC = 0.682) from healthy controls. Combined levels of these two miRNAs revealed an increased AUC of 0.812 for separating opisthorchiasis, AUC of 0.815 in discriminating PDF subjects, and AUC of 0.849 in differentiating CCA from healthy controls. Odds ratios (OR) indicated high levels of miR-192/miR-21 as risk predictors for opisthorchiasis, PDF and CCA. Levels of these miRNAs declined significantly for patients following praziquantel treatment. In conclusion, urinary miR-192/miR-21 have potential as risk indicators for opisthorchiasis and PDF-associated CCA in the endemic region.
KW - Cholangiocarcinoma
KW - Opisthorchis viverrini
KW - Periductal fibrosis
KW - Risk indicator
KW - Urinary microRNAs
UR - http://www.scopus.com/inward/record.url?scp=85020879618&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020879618&partnerID=8YFLogxK
U2 - 10.1016/j.parint.2015.10.001
DO - 10.1016/j.parint.2015.10.001
M3 - Article
C2 - 26456596
AN - SCOPUS:85020879618
SN - 1383-5769
VL - 66
SP - 479
EP - 485
JO - Parasitology International
JF - Parasitology International
IS - 4
ER -